472
Views
96
CrossRef citations to date
0
Altmetric
Review

Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases

, , , &
Pages 1569-1583 | Published online: 15 Mar 2018

References

  • AyanAKYenilmezAErogluHEvaluation of radiolabeled curcumin-loaded solid lipid nanoparticles usage as an imaging agent in liver-spleen scintigraphyMater Sci Eng C Mater Biol Appl20177566367028415513
  • ComogluTArisoySAkkusZBNanocarriers for effective brain drug deliveryCurr Top Med Chem201717131490150628017157
  • CoutoRAlvarezVTemelliFEncapsulation of Vitamin B2 in solid lipid nanoparticles using supercritical CO2J Supercrit Fluids2017120432442
  • SandriGMottaSBonferoniMCChitosan-coupled solid lipid nanoparticles: tuning nanostructure and mucoadhesionEur J Pharm Biopharm2017110131827989765
  • PistollatoFBremer-HoffmannSBassoGTargeting glioblastoma with the use of phytocompounds and nanoparticlesTarget Oncol2015111116
  • PistollatoFGiampieriFBattinoMThe use of plant-derived bioactive compounds to target cancer stem cells and modulate tumor microenvironmentFood Chem Toxicol201575587025445513
  • RamalingamPKoYTEnhanced oral delivery of curcumin from N-trim-ethyl chitosan surface-modified solid lipid nanoparticles: pharmacokinetic and brain distribution evaluationsPharm Res201532238940225082210
  • RamalingamPYooSWKoYTNanodelivery systems based on mucoadhesive polymer coated solid lipid nanoparticles to improve the oral intake of food curcuminFood Res Int201684113119
  • LeeWHLooCYYoungPMTrainiDMasonRSRohanizadehRRecent advances in curcumin nanoformulation for cancer therapyExpert Opin Drug Deliv20141181183120124857605
  • NiuZConejos-SanchezIGriffinBTO’DriscollCMAlonsoMJLipid-based nanocarriers for oral peptide deliveryAdv Drug Deliv Rev2016106Pt B33735427080735
  • RajaMAZeenatSArifMLiuCSelf-assembled nanoparticles based on amphiphilic chitosan derivative and arginine for oral curcumin deliveryInt J Nanomedicine2016114397441227660435
  • RamalingamPKoYTImproved oral delivery of resveratrol from N-trimethyl chitosan-g-palmitic acid surface-modified solid lipid nanoparticlesColloids Surf B Biointerfaces2016139526126700233
  • RamalingamPKoYTValidated LC-MS/MS method for simultaneous quantification of resveratrol levels in mouse plasma and brain and its application to pharmacokinetic and brain distribution studiesJ Pharm Biomed Anal2016119717526657178
  • Ikeuchi-TakahashiYIshiharaCOnishiHFormulation and evaluation of morin-loaded solid lipid nanoparticlesBiol Pharm Bull20163991514152227320782
  • GrandhiBKThakkarAWangJPrabhuSA novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesionsCancer Prev Res (Phila)20136101015102524072676
  • KakkarVMishraAKChuttaniKKaurIPProof of concept studies to confirm the delivery of curcumin loaded solid lipid nanoparticles (C-SLNs) to brainInt J Pharm2013448235435923558314
  • LiuJChenSLvLSongLGuoSHuangSRecent progress in studying curcumin and its nano-preparations for cancer therapyCurr Pharm Des201319111974199323116308
  • ShomeSTalukdarADChoudhuryMDBhattacharyaMKUpadhyayaHCurcumin as potential therapeutic natural product: a nanobiotechnological perspectiveJ Pharm Pharmacol201668121481150027747859
  • VijayakumarABaskaranRJangYSOhSHYooBKQuercetin-loaded solid lipid nanoparticle dispersion with improved physicochemical properties and cellular uptakeAAPS PharmSciTech201718387588327368922
  • SinghNKhullarNKakkarVKaurIPSesamol loaded solid lipid nanoparticles: a promising intervention for control of carbon tetrachloride induced hepatotoxicityBMC Complement Altern Med20151514225935744
  • SinghNKhullarNKakkarVKaurIPHepatoprotective effects of sesamol loaded solid lipid nanoparticles in carbon tetrachloride induced sub-chronic hepatotoxicity in ratsEnviron Toxicol201631552053225410024
  • KakkarVMuppuSKChopraKKaurIPCurcumin loaded solid lipid nanoparticles: an efficient formulation approach for cerebral ischemic reperfusion injury in ratsEur J Pharm Biopharm2013853 Pt A33934523454202
  • FrozzaRLBernardiAPaeseKCharacterization of trans-resveratrol-loaded lipid-core nanocapsules and tissue distribution studies in ratsJ Biomed Nanotechnol20106669470321361135
  • AhmadNBanalaVTKushwahaPQuercetin-loaded solid lipid nanoparticles improve osteoprotective activity in an ovariectomized rat model: a preventive strategy for post-menopausal osteoporosisRSC Adv201661009761397628
  • LuoCFYuanMChenMSPharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administrationInt J Pharm20114101–213814421392565
  • AdityaNPKoSSolid lipid nanoparticles (SLNs): delivery vehicles for food bioactivesRSC Adv20155393090230911
  • AdityaNPPatankarSMadhusudhanBMurthyRSRSoutoEBArthemeter-loaded lipid nanoparticles produced by modified thin-film hydration: pharmacokinetics, toxicological and in vivo anti-malarial activityEur J Pharm Sci201040544845520493255
  • AdityaNPAdityaSYangHKimHWParkSOKoSCo-delivery of hydrophobic curcumin and hydrophilic catechin by a water-in-oil-in-water double emulsionFood Chem201517371325465989
  • AdityaNPShimMYangHLeeYKoSAntiangiogenic effect of combined treatment with curcumin and genistein on human prostate cancer cell lineJ Funct Foods20148204213
  • ChoiKOAdityaNPKoSEffect of aqueous pH and electrolyte concentration on structure, stability and flow behavior of non-ionic surfactant based solid lipid nanoparticlesFood Chem201414723924424206712
  • AdityaNPAdityaSYangHJCurcumin and catechin co-loaded water-in-oil-in-water emulsion and its beverage applicationJ Funct Foods2015153543
  • AdityaNPMacedoASDoktorovovSDevelopment and evaluation of lipid nanocarriers for quercetin delivery: a comparative study of solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC), and lipid nanoemulsions (LNE)LWT Food Sci Technol2014591115121
  • JiPYuTLiuYNaringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokineticsDrug Des Devel Ther201610911925
  • KumarPSharmaGKumarRVitamin-derived nanolipoidal carriers for brain delivery of dimethyl fumarate: a novel approach with preclinical evidenceACS Chem Neurosci2017861390139628157295
  • LinglingGYuanZWeigenLPreparation, optimization, characterization and in vivo pharmacokinetic study of asiatic acid tromethamine salt-loaded solid lipid nanoparticlesDrug Dev Ind Pharm20164281325133326821124
  • MadureiraARCamposDGullonBFermentation of bioactive solid lipid nanoparticles by human gut microfloraFood Funct20167151652926606879
  • NevesARMartinsSSegundoMAReisSNanoscale delivery of resveratrol towards enhancement of supplements and nutraceuticalsNutrients20168313126950147
  • SiafakaPIUstundag OkurNKaravasEBikiarisDNSurface modified multifunctional and stimuli responsive nanoparticles for drug targeting: current status and usesInt J Mol Sci2016179
  • TanMEHeCHJiangWDevelopment of solid lipid nanoparticles containing total flavonoid extract from Dracocephalum moldavica L. and their therapeutic effect against myocardial ischemia-reperfusion injury in ratsInt J Nanomedicine2017123253326528458544
  • WangTMaXLeiYLuoYSolid lipid nanoparticles coated with cross-linked polymeric double layer for oral delivery of curcuminColloids Surf B Biointerfaces201614811127588376
  • DeningTJRaoSThomasNPrestidgeCAOral nanomedicine approaches for the treatment of psychiatric illnessesJ Control Release201622313715626739547
  • MaYHeHXiaFIn vivo fate of lipid-silybin conjugate nanoparticles: implications on enhanced oral bioavailabilityNanomedicine20171362643265428778838
  • NunesSMadureiraARCamposDSolid lipid nanoparticles as oral delivery systems of phenolic compounds: overcoming pharmacokinetic limitations for nutraceutical applicationsCrit Rev Food Sci Nutr20175791863187326192708
  • AnandKTilokeCNaidooPChuturgoonAAPhytonanotherapy for management of diabetes using green synthesis nanoparticlesJ Photochem Photobiol B201717362663928709077
  • BulleSReddyvariHNallanchakravarthulaVVaddiDRTherapeutic potential of Pterocarpus santalinus L.: an updatePharmacogn Rev20161019434927041873
  • ChenCYChiuFYLinYHuangWJHsiehPSHsuFLChemical constituents analysis and antidiabetic activity validation of four fern species from TaiwanInt J Mol Sci20151622497251625622260
  • DeyPSahaMRChowdhuriSRAssessment of anti-diabetic activity of an ethnopharmacological plant Nerium oleander through alloxan induced diabetes in miceJ Ethnopharmacol201516112813725498854
  • SinghAKJatwaRPurohitARamHSynthetic and phytocompounds based dipeptidyl peptidase-IV (DPP-IV) inhibitors for therapeutics of diabetesJ Asian Nat Prod Res201719101036104528351157
  • ChuengsamarnSRattanamongkolgulSLuechapudipornRPhisalaphongCJirawatnotaiSCurcumin extract for prevention of type 2 diabetesDiabetes Care201235112121212722773702
  • MovahedANabipourILieben LouisXAntihyperglycemic effects of short term resveratrol supplementation in type 2 diabetic patientsEvid Based Complement Alternat Med2013201385126724073011
  • XueMYangMXZhangWCharacterization, pharmacokinetics, and hypoglycemic effect of berberine loaded solid lipid nanoparticlesInt J Nanomedicine201384677468724353417
  • XueMZhangLYangMXBerberine-loaded solid lipid nanoparticles are concentrated in the liver and ameliorate hepatosteatosis in db/db miceInt J Nanomedicine2015105049505726346310
  • ChenSSMichaelAButler-ManuelSAAdvances in the treatment of ovarian cancer: a potential role of antiinflammatory phytochemicalsDiscov Med2012136871722284780
  • MahataSMaruSShuklaSAnticancer property of Bryophyllum pinnata (Lam.) Oken. leaf on human cervical cancer cellsBMC Complement Altern Med2012121522405256
  • NieQXingMHuJHuXNieSXieMMetabolism and health effects of phyto-estrogensCrit Rev Food Sci Nutr201757112432245426558495
  • RaniNVelanLPVijaykumarSArunachalamAAn insight into the potentially old-wonder molecule-quercetin: the perspectives in foreseeChin J Integr Med Epub201599
  • Davatgaran-TaghipourYMasoomzadehSFarzaeiMHPolyphenol nanoformulations for cancer therapy: experimental evidence and clinical perspectiveInt J Nanomedicine2017122689270228435252
  • ParkJSAhnEYParkYAsymmetric dumbbell-shaped silver nanoparticles and spherical gold nanoparticles green-synthesized by mangosteen (Garcinia mangostana) pericarp waste extractsInt J Nanomedicine2017126895690829066885
  • HazzahHAFaridRMNasraMMA new approach for treatment of precancerous lesions with curcumin solid-lipid nanoparticle-loaded gels: in vitro and clinical evaluationDrug Deliv20162341409141926146889
  • LiCZhangJZuYJBiocompatible and biodegradable nanoparticles for enhancement of anti-cancer activities of phytochemicalsChin J Nat Med201513964165226412423
  • NaksuriyaOOkonogiSSchiffelersRMHenninkWECurcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatmentBiomaterials201435103365338324439402
  • SunJBiCChanHMSunSZhangQZhengYCurcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailabilityColloids Surf B Biointerfaces201311136737523856543
  • KimJTBaruaSKimHAbsorption study of genistein using solid lipid microparticles and nanoparticles: control of oral bioavailability by particle sizesBiomol Ther (Seoul)201725445245928605834
  • WangLLiHWangSEnhancing the antitumor activity of berberine hydrochloride by solid lipid nanoparticle encapsulationAAPS PharmSciTech201415483484424696391
  • ChenRWangSZhangJChenMWangYAloe-emodin loaded solid lipid nanoparticles: formulation design and in vitro anti-cancer studyDrug Deliv201422566667424512431
  • ZhangQHXiongQPShiYYZhangDYStudy on preparation and characterization of resveratrol solid lipid nanoparticles and its anticancer effects in vitroZhong Yao Cai2010331219291932 Chinese [with English abstract]21548373
  • WangLWangSChenROridonin loaded solid lipid nanoparticles enhanced antitumor activity in MCF-7 cellsJ Nanomater20142014903646
  • JinQYuHLiPThe evaluation and utilization of marine-derived bioactive compounds with anti-obesity effectCurr Med Chem Epub201761
  • PanMHTungYCYangGLiSHoCTMolecular mechanisms of the anti-obesity effect of bioactive compounds in tea and coffeeFood Funct20167114481449127722362
  • MerelesDHunsteinWEpigallocatechin-3-gallate (EGCG) for clinical trials: more pitfalls than promises?Int J Mol Sci20111295592560322016611
  • FriasINevesARPinheiroMReisSDesign, development, and characterization of lipid nanocarriers-based epigallocatechin gallate delivery system for preventive and therapeutic supplementationDrug Des Devel Ther20161035193528
  • HemnHONoordinMMRahmanHSHazilawatiHZukiAChartrandMSAntihypercholesterolemic and antioxidant efficacies of zerumbone on the formation, development, and establishment of atherosclerosis in cholesterol-fed rabbitsDrug Des Devel Ther2015941734208
  • ChangCCLinKYPengKYDayYJHungLMResveratrol exerts anti-obesity effects in high-fat diet obese mice and displays differential dosage effects on cytotoxicity, differentiation, and lipolysis in 3T3-L1 cellsEndocr J201663216917826698690
  • VijayakumarABaskaranRJangYSOhSHYooBKQuercetin-loaded solid lipid nanoparticle dispersion with improved physicochemical properties and cellular uptakeAAPS PharmSciTech201618387588327368922
  • OlasBSea buckthorn as a source of important bioactive compounds in cardiovascular diseasesFood Chem Toxicol20169719920427616182
  • Rangel-HuertaODPastor-VillaescusaBAguileraCMGilAA systematic review of the efficacy of bioactive compounds in cardiovascular disease: phenolic compoundsNutrients2015775177521626132993
  • SolaRVallsRMPuzoJEffects of poly-bioactive compounds on lipid profile and body weight in a moderately hypercholesterolemic population with low cardiovascular disease risk: a multicenter randomized trialPLoS One201498e10197825084280
  • MalagutiMAngeloniCHreliaSNutraceutical bioactive compounds promote healthspan counteracting cardiovascular diseasesJ Am Coll Nutr201534Suppl 1222726400430
  • Pastor-VillaescusaBRangel-HuertaODAguileraCMGilAA systematic review of the efficacy of bioactive compounds in cardiovascular disease: carbohydrates, active lipids and nitrogen compoundsAnn Nutr Metab2015662–316818126045206
  • ScolaroBSoo Jin KimHde CastroIABioactive compounds as an alternative for drug co-therapy: overcoming challenges in cardiovascular disease preventionCrit Rev Food Sci Nutr Epub20161110114
  • LuoCFChenMSProfessorYMetabolic profile of puerarin in rats after intragastric administration of puerarin solid lipid nanoparticlesInt J Nanomedicine2013893394023486407
  • EzhilarasiPNMuthukumarSPAnandharamakrishnanCSolid lipid nanoparticle enhances bioavailability of hydroxycitric acid compared to a microparticle delivery systemRSC Adv20166595378453793
  • GuptaSCTyagiAKDeshmukh-TaskarPHinojosaMPrasadSAggarwalBBDownregulation of tumor necrosis factor and other proinflammatory biomarkers by polyphenolsArch Biochem Biophys2014559919924946050
  • KhalifeSZafarullahMMolecular targets of natural health products in arthritisArthritis Res Ther201113110221345249
  • RahmanMBegSVermaAPhytoconstituents as pharmacotherapeutics in rheumatoid arthritis: challenges and scope of nano/submicromedicine in its effective deliveryJ Pharm Pharmacol201769111427774648
  • MobasheriAHenrotinYBiesalskiHKShakibaeiMScientific evidence and rationale for the development of curcumin and resveratrol as nutraceutricals for joint healthInt J Mol Sci20121344202423222605974
  • RecioMCAndujarIRiosJLAnti-inflammatory agents from plants: progress and potentialCurr Med Chem201219142088210322414101
  • ShakibaeiMMobasheriABuhrmannCCurcumin synergizes with resveratrol to stimulate the MAPK signaling pathway in human articular chondrocytes in vitroGenes Nutr20116217117921484156
  • BhalekarMRMadgulkarARDesalePSMariumGFormulation of piperine solid lipid nanoparticles (SLN) for treatment of rheumatoid arthritisDrug Dev Ind Pharm20174361003101028161984
  • AroraRKuhadAKaurIPChopraKCurcumin loaded solid lipid nanoparticles ameliorate adjuvant-induced arthritis in ratsEur J Pain201519794095225400173
  • ChenJWeiNLopez-GarciaMDevelopment and evaluation of resveratrol, Vitamin E, and epigallocatechin gallate loaded lipid nanoparticles for skin care applicationsEur J Pharm Biopharm201711728629128411056
  • Fonseca-SantosBGremiaoMPChorilliMNanotechnology-based drug delivery systems for the treatment of Alzheimer’s diseaseInt J Nanomedicine2015104981500326345528
  • LoureiroJAAndradeSDuarteAResveratrol and grape extract-loaded solid lipid nanoparticles for the treatment of Alzheimer’s diseaseMolecules2017222
  • PiconePBondiMLMontanaGFerulic acid inhibits oxidative stress and cell death induced by Ab oligomers: improved delivery by solid lipid nanoparticlesFree Radic Res200943111133114519863373
  • SachdevaAKMisraSPal KaurIChopraKNeuroprotective potential of sesamol and its loaded solid lipid nanoparticles in ICV-STZ-induced cognitive deficits: behavioral and biochemical evidenceEur J Pharmacol201574713214025449035
  • YusufMKhanMKhanRAAhmedBPreparation, characterization, in vivo and biochemical evaluation of brain targeted Piperine solid lipid nanoparticles in an experimentally induced Alzheimer’s disease modelJ Drug Target2012213300311
  • BarbuEMolnarETsibouklisJGoreckiDCThe potential for nanoparticle-based drug delivery to the brain: overcoming the blood-brain barrierExpert Opin Drug Deliv20096655356519435406
  • FilipovaMRusinaRHoladaKNanoparticle-based drug delivery systems crossing blood-brain barrier – hope for future treatment of neurodegenerative disorders?Cesk Slov Neurol N2016792160167
  • ShahBKhuntDBhattHMisraMPadhHApplication of quality by design approach for intranasal delivery of rivastigmine loaded solid lipid nanoparticles: effect on formulation and characterization parametersEur J Pharm Sci201578546626143262
  • WilsonCMMagnaudeixANavesTVincentFLalloueFJauber-teauMOThe ins and outs of nanoparticle technology in neurodegenerative diseases and cancerCurr Drug Metab201516860963226264207
  • ZhangGLChenLKGuoXYKhanAAGuYCGuNNanoparticle-mediated drug delivery systems (DDS) in the central nervous systemCurr Org Chem2017213272283
  • DhawanSKapilRSinghBFormulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain deliveryJ Pharm Pharmacol201163334235121749381
  • BondiMLMontanaGCraparoEFFerulic acid-loaded lipid nanostructures as drug delivery systems for Alzheimer’s disease: preparation, characterization and cytotoxicity studiesCurr Nanosci2009512632
  • BarbaraRBellettiDPederzoliFNovel curcumin loaded nanoparticles engineered for blood-brain barrier crossing and able to disrupt Abeta aggregatesInt J Pharm20175261–241342428495580
  • BattistiAPiccionelloAPSgarbossaACurcumin-like compounds designed to modify amyloid beta peptide aggregation patternsRSC Adv20177503171431724
  • ChandraBMithuVSBhowmikDCurcumin dictates divergent fates for the central salt bridges in amyloid-β40 and amyloid-β42Biophys J201711281597160828445751
  • Di MartinoPCensiRGigliobiancoMRNano-medicine improving the bioavailability of small molecules for the prevention of neurodegenerative diseasesCurr Pharm Des201723131897190828025942
  • JaroonwitchawanTChaicharoenaudomrungNNatnkaewJNoisaPCurcumin attenuates paraquat-induced cell death in human neuroblastoma cells through modulating oxidative stress and autophagyNeurosci Lett2017636404727793699
  • KarimianMSPirroMJohnstonTPMajeedMSahebkarACurcumin and endothelial function: evidence and mechanisms of protective effectsCurr Pharm Des201723172462247328228072
  • McClureROngHJanveVAerosol delivery of curcumin reduced amyloid-β deposition and improved cognitive performance in a transgenic model of Alzheimer’s diseaseJ Alzheimers Dis201755279781127802223
  • UllahFLiangARangelAGyengesiENiedermayerGMunchGHigh bioavailability curcumin: an anti-inflammatory and neurosupportive bioactive nutrient for neurodegenerative diseases characterized by chronic neuroinflammationArch Toxicol20179141623163428204864
  • ZengZShenZLZhaiSTransport of curcumin derivatives in Caco-2 cell monolayersEur J Pharm Biopharm201711712313128396278
  • KakkarVKaurIPEvaluating potential of curcumin loaded solid lipid nanoparticles in aluminium induced behavioural, biochemical and histopathological alterations in mice brainFood Chem Toxicol201149112906291321889563
  • AhmedTJavedSJavedSResveratrol and Alzheimer’s disease: mechanistic insightsMol Neurobiol20175442622263526993301
  • ChengJRuiYQinLVitamin D combined with resveratrol prevents cognitive decline in SAMP8 miceCurr Alzheimer Res201714882083328176624
  • FameniniSRigaliEAOlivera-PerezHMIncreased intermediate M1–M2 macrophage polarization and improved cognition in mild cognitive impairment patients on omega-3 supplementationFASEB J201731114816027677546
  • HeXLiZRizakJDResveratrol attenuates formaldehyde induced hyperphosphorylation of Tau protein and cytotoxicity in N2a cellsFront Neurosci20161059828197064
  • JerabekJUliassiEGuidottiLTacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer’s diseaseEur J Med Chem201712725026228064079
  • MoussaCHebronMHuangXResveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s diseaseJ Neuroinflammation2017141128086917
  • NoratiqahSBNaina-MohamedIZulfarinaMSQodriyahHMNatural polyphenols in the treatment of Alzheimer’s diseaseCurr Drug Targets Epub2017328
  • OmarSHScottCJHamlinASObiedHKThe protective role of plant biophenols in mechanisms of Alzheimer’s diseaseJ Nutr Biochem20174712028301805
  • WightmanELPotential benefits of phytochemicals against Alzheimer’s diseaseProc Nutr Soc201776210611228143625
  • XuPZhangMShengRMaYSynthesis and biological evaluation of deferiprone-resveratrol hybrids as antioxidants, Abeta1-42 aggregation inhibitors and metal-chelating agents for Alzheimer’s diseaseEur J Med Chem201712717418628061347
  • CuryRGFraixVCastriotoAThalamic deep brain stimulation for tremor in Parkinson disease, essential tremor, and dystoniaNeurology201789131416142328768840
  • KanegusukuHSilva-BatistaCPecanhaTPatients with Parkinson disease present high ambulatory blood pressure variabilityClin Physiol Funct Imaging201737553053528776928
  • ParkJLeeJWCooperSCBroxmeyerHECannonJRKimCHParkinson disease-associated LRRK2 G2019S transgene disrupts marrow myelopoiesis and peripheral Th17 responseJ Leukoc Biol201710241093110228751472
  • RamirezAIde HozRSalobrar-GarciaEThe role of microglia in retinal neurodegeneration: Alzheimer’s disease, Parkinson, and glaucomaFront Aging Neurosci2017921428729832
  • Saez-AtienzarSSingletonABParkinson disease and clathrin coat dynamics at synapses, why not?Mov Disord2017328116328681957
  • SonHJJeongYJYoonHJParkinson disease-related cortical and striatal cognitive patterns in dual time F-18 FP CIT: evidence for neural correlates between the caudate and the frontal lobeQ J Nucl Med Mol Imaging Epub2017727
  • StruppJKundeAGalushkoMVoltzRGollaHSeverely affected by Parkinson disease: the patient’s view and implications for palliative careAm J Hosp Palliat Care Epub201711
  • da CostaIMCavalcantiJRLPde QueirozDBSupplementation with herbal extracts to promote behavioral and neuroprotective effects in experimental models of Parkinson’s disease: a systematic reviewPhytother Res201731795997028544038
  • GanesanPKoHMKimISChoiDKRecent trends in the development of nanophytobioactive compounds and delivery systems for their possible role in reducing oxidative stress in Parkinson’s disease modelsInt J Nanomedicine2015106757677226604750
  • GokulKMuralidharaOral supplements of aqueous extract of tomato seeds alleviate motor abnormality, oxidative impairments and neurotoxicity induced by rotenone in mice: relevance to Parkinson’s diseaseNeurochem Res20143971382139424831121
  • GuoHShiFLiMLiuQYuBHuLNeuroprotective effects of Eucommia ulmoides Oliv. and its bioactive constituent work via ameliorating the ubiquitin-proteasome systemBMC Complement Altern Med20151515125994206
  • KlionskyDJAbdelmohsenKAbeAGuidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)Autophagy2016121122226799652
  • MazoNAEcheverriaVCabezasRMedicinal plants as protective strategies against Parkinson’s diseaseCurr Pharm Des201723284180418828302024
  • MorshediDAliakbariFTayaranian-MarvianAFassihiAPan-MontojoFPérez-SánchezHCuminaldehyde as the major component of Cuminum cyminum, a natural aldehyde with inhibitory effect on alpha-synuclein fibrillation and cytotoxicityJ Food Sci20158010H2336H234526351865
  • MythriRBHarishGBharathMMTherapeutic potential of natural products in Parkinson’s diseaseRecent Pat Endocr Metab Immune Drug Discov20126318120022827714
  • NabaviSFBraidyNHabtemariamSSuredaAManayiANabaviSMNeuroprotective effects of fisetin in Alzheimer’s and Parkinson’s diseases: from chemistry to medicineCurr Top Med Chem201616171910191526845554
  • PathakASrivastavaAKSingourPKGoudaPSynthetic and natural monoamine oxidase inhibitors as potential lead compounds for effective therapeuticsCent Nerv Syst Agents Med Chem2016162819726104056
  • SolankiIPariharPMansuriMLPariharMSFlavonoid-based therapies in the early management of neurodegenerative diseasesAdv Nutr201561647225593144
  • CacciatoreICiullaMFornasariEMarinelliLDi StefanoASolid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseasesExpert Opin Drug Deliv20161381121113127073977
  • CunhaSAmaralMHLoboJMSilvaACTherapeutic strategies for Alzheimer’s and Parkinson’s diseases by means of drug delivery systemsCurr Med Chem201623313618363127554805
  • ChenTDengYLiaoXEffect of curcumin on oligomer formation and mitochondrial ATP-sensitive potassium channels induced by overexpression or mutation of α-synucleinZhonghua Yi Xue Yi Chuan Xue Za Zhi2015324462467 Chinese [with English abstract]26252085
  • CuiQLiXZhuHCurcumin ameliorates dopaminergic neuronal oxidative damage via activation of the Akt/Nrf2 pathwayMol Med Rep20161321381138826648392
  • DuXXXuHMJiangHSongNWangJXieJXCurcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hydroxydopamine rat model of Parkinson’s diseaseNeurosci Bull201228325325822622825
  • Guerrero-MuñozMJCastillo-CarranzaDLKayedRTherapeutic approaches against common structural features of toxic oligomers shared by multiple amyloidogenic proteinsBiochem Pharmacol201488446847824406245
  • PhomLAchumiBAloneDPMuralidharaYenisettiSCCurcumin’s neuroprotective efficacy in Drosophila model of idiopathic Parkinson’s disease is phase specific: implication of its therapeutic effectivenessRejuvenation Res201417648148925238331
  • SongSNieQLiZDuGCurcumin improves neurofunctions of 6-OHDA-induced parkinsonian ratsPathol Res Pract2016212424725126922613
  • SpinelliKJOsterbergVRMeshulCKSoumyanathAUnniVKCurcumin treatment improves motor behavior in α-synuclein transgenic micePLoS One2015106e012851026035833
  • UğuzACÖzANaziroğluMCurcumin inhibits apoptosis by regulating intracellular calcium release, reactive oxygen species and mitochondrial depolarization levels in SH-SY5Y neuronal cellsJ Recept Signal Transduct Res201636439540126608462
  • YuSYZhangMLuoJZhangLShaoYLiGCurcumin ameliorates memory deficits via neuronal nitric oxide synthase in aged miceProg Neuropsychopharmacol Biol Psychiatry201345475323665290
  • Abdel-WahabWMThymoquinone attenuates toxicity and oxidative stress induced by bisphenol A in liver of male ratsPak J Biol Sci201417111152116026027160
  • BabuPRBhuvaneswarCSandeepGRamaiahCVRajendraWHepatoprotective role of Ricinus communis leaf extract against d-galactosamine induced acute hepatitis in albino ratsBiomed Pharmacother20178865866628152474
  • DongiovanniPLantiCRisoPValentiLNutritional therapy for nonalcoholic fatty liver diseaseJ Nutr Biochem20162911126895659
  • El-HadaryAERamadan HassanienMFHepatoprotective effect of cold-pressed Syzygium aromaticum oil against carbon tetrachloride (CCl4)-induced hepatotoxicity in ratsPharm Biol20165481364137226440388
  • FuYQHuaCZhouJChengBRZhangJProtective effects of ginseng total saponins against hepatic ischemia/reperfusion injury in experimental obstructive jaundice ratsPharm Biol201351121545155124004049
  • HuangHPOuTTWangCJMulberry (sang shen zi) and its bioactive compounds, the chemoprevention effects and molecular mechanisms in vitro and in vivoJ Tradit Complement Med20133171524716151
  • InadaACFigueiredoPSSantos-EichlerRADMorinda citrifolia Linn. (Noni) and its potential in obesity-related metabolic dysfunctionNutrients201796
  • KowalskaKOlejnikACurrent evidence on the health-beneficial effects of berry fruits in the prevention and treatment of metabolic syndromeCurr Opin Clin Nutr Metab Care201619644645227583706
  • MopuriRIslamMSMedicinal plants and phytochemicals with anti-obesogenic potentials: a reviewBiomed Pharmacother2017891442145228372259
  • Rodriguez-RamiroIVauzourDMinihaneAMPolyphenols and non-alcoholic fatty liver disease: impact and mechanismsProc Nutr Soc2016751476026592314
  • SamoutNEttayaABouzennaHNcibSElfekiAHfaiedhNBeneficial effects of Plantago albicans on high-fat diet-induced obesity in ratsBiomed Pharmacother2016841768177527876214
  • ValentiLRisoPMazzocchiAPorriniMFargionSAgostoniCDietary anthocyanins as nutritional therapy for nonalcoholic fatty liver diseaseOxid Med Cell Longev2013201314542124282628
  • XuWHHuHGTianYBioactive compound reveals a novel function for ribosomal protein S5 in hepatic stellate cell activation and hepatic fibrosisHepatology201460264866024668691
  • YuJYHaJYKimKMJungYSJungJCOhSAnti-inflammatory activities of licorice extract and its active compounds, glycyrrhizic acid, liquiritin and liquiritigenin, in BV2 cells and mice liverMolecules2015207130411305426205049
  • AbdelwahabSISheikhBYTahaMMThymoquinone-loaded nanostructured lipid carriers: preparation, gastroprotection, in vitro toxicity, and pharmacokinetic properties after extravascular administrationInt J Nanomedicine201382163217223818776
  • NaseriNValizadehHZakeri-MilaniPSolid lipid nanoparticles and nanostructured lipid carriers: structure, preparation and applicationAdv Pharm Bull20155330531326504751
  • RaoMPManjunathKBhagawatiSTThippeswamyBSBixin loaded solid lipid nanoparticles for enhanced hepatoprotection – preparation, characterisation and in vivo evaluationInt J Pharm20144731–248549225066077
  • ShuhendlerAJPrasadPLeungMRauthAMDacostaRSWuXYA novel solid lipid nanoparticle formulation for active targeting to tumor α(v) β(3) integrin receptors reveals cyclic RGD as a double-edged swordAdv Healthc Mater20121560060823184795
  • SharmaAKKumarAKumarSPreparation and therapeutic evolution of Ficus benjamina solid lipid nanoparticles against alcohol abuse/antabuse induced hepatotoxicity and cardio-renal injuryRSC Adv20177573593835949
  • KakkarVMishraAKChuttaniKChopraKKaurIPDelivery of sesamol-loaded solid lipid nanoparticles to the brain for menopause-related emotional and cognitive central nervous system derangementsRejuvenation Res201114659760421978086
  • ElzoghbyAOAbd-ElwakilMMAbd-ElsalamKElsayedMTHashemYMohamedONatural polymeric nanoparticles for brain-targeting: implications on drug and gene deliveryCurr Pharm Des201622223305332326845323
  • FontePAndradeFAraújoFAndradeCNevesJDSarmentoBChitosan-coated solid lipid nanoparticles for insulin deliveryMethods Enzymol201250829531422449932
  • LuoYTengZLiYWangQSolid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptakeCarbohyd Polym2015122221229
  • BaekJSChoCWSurface modification of solid lipid nanoparticles for oral delivery of curcumin: improvement of bioavailability through enhanced cellular uptake, and lymphatic uptakeEur J Pharm Biopharm201711713214028412471
  • CamposJVaras-GodoyMHaidarZSPhysicochemical characterization of chitosan-hyaluronan-coated solid lipid nanoparticles for the targeted delivery of paclitaxel: a proof-of-concept study in breast cancer cellsNanomedicine (Lond)201712547349028181464
  • NguyenHMHwangICParkJWParkHJPhotoprotection for deltamethrin using chitosan-coated beeswax solid lipid nanoparticlesPest Manag Sci20126871062106822383397
  • RassuGSodduEPosadinoAMNose-to-brain delivery of BACE1 siRNA loaded in solid lipid nanoparticles for Alzheimer’s therapyColloids Surf B Biointerfaces201715229630128126681
  • WangJYWangYMengXChitosan nanolayered cisplatin-loaded lipid nanoparticles for enhanced anticancer efficacy in cervical cancerNanoscale Res Lett201611152427888498
  • ThakkarAChenreddySWangJPrabhuSFerulic acid combined with aspirin demonstrates chemopreventive potential towards pancreatic cancer when delivered using chitosan-coated solid-lipid nanoparticlesCell Biosci201554626301084
  • ThakkarAChenreddySThioAKhamasWWangJPrabhuSPreclinical systemic toxicity evaluation of chitosan-solid lipid nanoparticle-encapsulated aspirin and curcumin in combination with free sulforaphane in BALB/c miceInt J Nanomedicine2016113265327627499621
  • FathiMMirlohiMVarshosazJMadaniGNovel caffeic acid nanocarrier: production, characterization, and release modelingJ Nanomater20132013434632
  • ChenFZhangZRYuanFQinXWangMHuangYIn vitro and in vivo study of N-trimethyl chitosan nanoparticles for oral protein deliveryInt J Pharm20083491–222623317825506
  • HanLTangCYinCOral delivery of shRNA and siRNA via multifunctional polymeric nanoparticles for synergistic cancer therapyBiomaterials201435154589460024613049
  • ZhangJTangCYinCGalactosylated trimethyl chitosan-cysteine nanoparticles loaded with Map4k4 siRNA for targeting activated macrophagesBiomaterials201334143667367723419643
  • ShiLLLuJCaoYGastrointestinal stability, physicochemical characterization and oral bioavailability of chitosan or its derivative-modified solid lipid nanoparticles loading docetaxelDrug Dev Ind Pharm201743583984627487431
  • CaiJDangQLiuCPreparation, characterization and antibacterial activity of O-acetyl-chitosan-N-2-hydroxypropyl trimethyl ammonium chlorideInt J Biol Macromol20158081526093196
  • LiGFWangJCFengXMLiuZDJiangCYYangJDPreparation and testing of quaternized chitosan nanoparticles as gene delivery vehiclesAppl Biochem Biotechnol201517573244325725686559
  • XiaoBMaPMaLEffects of tripolyphosphate on cellular uptake and RNA interference efficiency of chitosan-based nanoparticles in Raw 264.7 macrophagesJ Colloid Interface Sci201749052052827918990
  • YangZShangYHuangXCationic content effects of biodegradable amphoteric chitosan-based flocculants on the flocculation propertiesJ Environ Sci (China)20122481378138523513678
  • ZhaoKSunYChenGBiological evaluation of N-2-hydroxypropyl trimethyl ammonium chloride chitosan as a carrier for the delivery of live Newcastle disease vaccineCarbohydr Polym2016149283927261727
  • ShiLLXieHLuJPositively charged surface-modified solid lipid nanoparticles promote the intestinal transport of docetaxel through multifunctional mechanisms in ratsMol Pharm20161382667267627379550
  • RezzaniRRodellaLFFraschiniFMelatonin delivery in solid lipid nanoparticles: prevention of cyclosporine A induced cardiac damageJ Pineal Res200946325526119196438
  • KarthivashanGGanesanPParkSKimJChoiDTherapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer’s diseaseDrug delivery201825130732029350055
  • SayinBSomavarapuSLiXWSesardicDSenelSAlparOHTMC–MCC (N-trimethyl chitosan–mono-N-carboxymethyl chitosan) nanocomplexes for mucosal delivery of vaccinesEur J Pharm Sci200938436236919733658
  • YinLDingJHeCCuiLTangCYinCDrug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin deliveryBiomaterials200930295691570019615735
  • SlütterBSoemaPCDingZVerheulRHenninkWJiskootWConjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigenJ Control Release2010143220721420074597